Abstract: The present invention relates to compositions and methods for treating rheumatic diseases, such as psoriasis arthropathica, by administering to a subject a CTLA4 molecule that block endogenous B7 molecules from binding their ligands.
Agent: Bristol-myers Squibb Company - , Inventors: Robert Cohen, Suzette Carr, David Hagerty, Robert James Peach, Jean-Claude BeckerUSPTO Applicaton #: #20110311529 - Class: 4241331 (USPTO)
The Patent
No comments:
Post a Comment